Glow-in-the-Dark dye could simplify vulvar cancer surgery

NCT ID NCT06035068

Not yet recruiting Diagnosis Sponsor: Tufts Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will test whether a fluorescent dye called indocyanine green (ICG), used with a special handheld camera, can find sentinel lymph nodes as well as the standard blue dye in early-stage vulvar cancer. Ten patients will receive both dyes during surgery, and doctors will compare how often each method spots the nodes. If ICG works just as well, it could make the procedure simpler and more accessible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Indocyanine green (ICG) dye
What this could lead to: If it works, this could offer a simpler, less invasive way to map lymph nodes in vulvar cancer, potentially making the procedure easier for patients and doctors.
What could go wrong: This is a very small pilot study with only 10 participants, so results may not apply to everyone. The ICG method might not be as accurate as the standard blue dye approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY-STAGE VULVAR SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vulva cancer vulvar squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VULVA CANCER

Contacts and locations

Locations

Tufts Medical Center

Boston, Massachusetts, 02111, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.